Swedencare Ab · OMXSTO:SECARE
Swedencare Ab — Q3 2022 Earnings Presentation
11 slides from Swedencare Ab's earnings presentation, September 2022
Slide 1: Q3 Interim Report July – September 2022
Q3 INTERIM REPORT July – September 2022 Presentation CEO Håkan Lagerberg CFO Jenny Graflind
Slide 2: Q3 2022 Highlights
Q3 2022 Highlights Strong market despite unstable environment Sales record and solid demand despite world situation Organic growth 8% Record quarters for several group companies Ongoing major agreements impacted sales Many collaborating initiatives within the group
Slide 3: Operational Net sales and EBITDA
Operational Net sales (MSEK) EBITDA (MSEK) 600 120 500 100 400 80 % 9% 70 11 300 60 20,1% 200 40 25,5% 100 20 0 - Q3 2021 Q3 2022 Q3 2021 Q3 2022
Slide 4: Key Performance Indicators Q3 2022
Key Performance Indicators Q3 2022
Slide 5: Net Sales by region (MSEK) – 84% of total
Net Sales by region (MSEK) – 84% of total North America 450 • Continued quarterly growth despite inventory 400 shrinkage among top customers 350 • Strong end customer demand, shown both from 300 customer reports and own online sales 14 3% • Several intra group projects – synergies – cost & 250 new b
Slide 6: Net Sales by region (MSEK) – 14% of total
Net Sales by region (MSEK) – 14% of total • Italy strong – double digit growth, softer RoE Europe • Sales affected by retroactive price adjustment 100 and inventory adjustment for Nutravet 90 • New 7-year contract with Europe’s largest 80 Veterinary group for UK/IRL 70 • D2C Nutravet online shop 60
Slide 7: Net Sales by region (MSEK) – 2%
Net Sales by region (MSEK) – 2% Rest of the world 16 • Brazil strongest ever with both ProDen PlaqueOff®(“PO”) and Pet food project 14 12 • South Korea for PO, NaturVet and nutravet 10 • Japan continue to grow PO in Pet retail 8 69% • China still lock down but expecting order in Q4 and a 6 significa
Slide 8: Rolling Quarters
Rolling 4 Quarters 1500}... 1400)... 1300}... 1200]... 1100 1000]... 900 |... 800 700 |... 600 |... 500 |... 400 300 |... 200}. 100 Qi Q2 Q@3 G4 QI Q2 QB Q4 QI Q2 QO QA4 QI Q2 QB 2019 2020 2021 2022 (Net revenue MN EBITDA (ME Operational EBITDA 8 SWEDENCARE
Slide 9: Priorities 2022/2023
Priorities 2022/2023 International sales Launch of Soft Chews in Europe and international, both labeled and PL Product launches and development Utilizing group resources and other synergies Growing and solidifying relationships with major customers M&A opportunities
Slide 10: Q&A
Q&A 1. It’s now been one year since the patent for ProDen PlaqueOff® expired. Has the competitive landscape changed and are you surprised by the continued strong growth? 2. Why was there a retroactive price adjustment made in the quarter and what was the amount? 3. Was their any material damages fro
Slide 11: See you soon!
Live Chat starts in 5 min – See you soon!